The value of phentolamine pump in the treatment of neonatal necrotizing enterocolitis
酚妥拉明泵治疗新生儿坏死性小肠结肠炎的价值研究

摘要

目的 探析酚妥拉明泵应用于新生儿坏死性小肠结肠炎治疗中的实际成效。方法 选择2023年10月至2024年10月我院收治的60例坏死性小肠结肠炎患儿为研究样本，依照随机数字表法设为两组，即参考组和实验组，参考组采取常规治疗，实验组在常规治疗的基础上加用酚妥拉明泵治疗。比较两组治疗效果。结果 实验组的各项炎性因子水平均明显更低（P<0.05）；实验组的肠内营养恢复时间、大便恢复正常时间及腹胀消失时间均明显更短（P<0.05）。结论 酚妥拉明泵治疗新生儿坏死性小肠结肠炎具有显著的临床效果，能够大大降低炎性因子水平，促进患儿恢复，值得临床推广。

Abstract

Objective To explore the actual effectiveness of using phentolamine pump in the treatment of neonatal necrotizing enterocolitis.
Methods Sixty children with necrotizing enterocolitis admitted to our hospital from October 2023 to October 2024 were selected as the study sample. They were randomly divided into two groups according to the random number table method, namely the reference group and the experimental group. The reference group received conventional treatment, while the experimental group received phentolamine pump treatment in addition to conventional treatment. Compare the therapeutic effects of two groups.
Results The levels of various inflammatory factors in the experimental group were significantly lower (P<0.05); The recovery time of enteral nutrition, normal bowel movements, and disappearance of abdominal distension in the experimental group were significantly shorter (P<0.05).
Conclusion   Phentolamine pump has significant clinical effects in the treatment of neonatal necrotizing enterocolitis, which can greatly reduce the levels of inflammatory factors and promote the recovery of children. It is worthy of clinical promotion.